USPTO serial 79430352
CP COMPLEX PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2026
- Examiner
- GANESH, HARINI
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CP COMPLEX PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AT
AT
AT
AT
AT
AT
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, analgesics, opioid antagonists, and beta blockers; pharmaceuticals for treatment purposes used in the fields of intensive care and emergency medicine, anesthesia, hematooncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry; medical preparations for the treatment of pain conditions, in particular, pain management, postoperative pain, oncology-related pain, and palliative care; medical preparations for the treatment of cardiologic conditions, in particular, tachycardia, cardiac arrhythmias, acute hypertension, and perioperative cardiovascular management; medical preparations for the treatment of opioid-related conditions, in particular, opioid overdose, opioid-induced respiratory depression, and addiction treatment; medical preparations for treatment purposes used in the fields of intensive care and emergency medicine, anesthesia, hematooncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry; prescription synthetic narcotics; poisons, namely medical or pharmaceutical poisons in the nature of cytotoxic agents and neurotoxic compounds administered in controlled dosages for therapeutic, diagnostic, or veterinary purposes for use in oncology, intensive care, and neurological treatment | ACTIVE | — |
| 010 | Medical apparatus and devices, namely, drug delivery devices sold empty, in particular, insulin pens, autoinjectors, inhalers, oral films, and infusion sets; Medical apparatus and devices, namely, primary containers for administering medication, sold empty, in particular, cartridges, vials, plastic and polyethylene dropper bottles for administering medication, and infusion bags; Medical devices for delivering medications, namely, safety needles, pen needles, standard needles being medical syringes, and vial adapters; all of the aforementioned goods for use in the fields of intensive care, emergency medicine, anesthesia, hematology-oncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry, and for diagnostic and therapeutic purposes | ACTIVE | — |
| 035 | Arranging of trading transactions for pharmaceuticals, narcotics, poisons, medical preparations, medical apparatus and devices; wholesale store and distributorship services of pharmaceuticals, narcotics, poisons, medical preparations, medical apparatus and devices | ACTIVE | — |
| 039 | Transport of goods; transport of goods in the nature of pharmaceuticals, narcotics, poisons, medical preparations, medical apparatus and devices; packaging and storage of goods, namely, pharmaceuticals, narcotics, poisons, medical preparations, medical apparatus, and devices; distribution services, namely, delivery of pharmaceuticals, narcotics, poisons, medical preparations, medical apparatus and devices; labelling services for the merchandise of others; transportation logistics in the nature of supply chain logistics and reverse logistics services for the pharmaceutical industry, namely, storage, transportation and delivery of goods for others by air, rail, ship or truck; shipping of goods | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; contract manufacturing services in the fields of pharmaceuticals, narcotics, poisons, medical preparations, medical products, and medical apparatus and devices | ACTIVE | — |
| 042 | Quality control for others; quality control testing of goods and services; quality control of manufactured goods for others | ACTIVE | — |
| 044 | Medical services; advisory services relating to pharmaceuticals, narcotics, poisons, medical preparations, and medical apparatus and devices; medical equipment rental; consultancy and information services relating to pharmaceuticals, narcotics, poisons, medical preparations, medical products, and medical apparatus and devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks owned by Complex Pharmaceuticals GmbH
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CP COMPLEX PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 11, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 23, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 23, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 13, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 13, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 29, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 20, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 19, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |